GE HealthCare Technologies (GEHC) EBIT (2022 - 2026)

GE HealthCare Technologies has reported EBIT for 5 years, with the latest figure at $515.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 18.12% year-over-year to $515.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 billion (down 2.39% YoY), and the FY2025 full-year result was $2.8 billion, up 5.26% from the prior year.
• EBIT for Q1 2026 stood at $515.0 million, down from $827.0 million in the prior quarter.
• The five-year high for EBIT was $827.0 million in Q4 2025, with the low at $509.0 million in Q1 2022.
• Historically, EBIT has averaged $638.8 million across 5 years, with a median of $629.0 million in 2025.
• Annual changes were most pronounced in 2025 — EBIT increased 16.48% — and 2026, when it slipped 18.12%.
• GE HealthCare Technologies' EBIT stood at $777.0 million in 2022, then retreated by 11.33% to $689.0 million in 2023, then advanced by 16.26% to $801.0 million in 2024, then advanced by 3.25% to $827.0 million in 2025, then tumbled by 37.73% to $515.0 million in 2026.
• The last three EBIT figures came in at $515.0 million (Q1 2026), $827.0 million (Q4 2025), and $653.0 million (Q3 2025), per Business Quant data.